Latest Insider Transactions at Diffusion Pharmaceuticals Inc. (DFFN)
This section provides a real-time view of insider transactions for Diffusion Pharmaceuticals Inc. (DFFN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Diffusion Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Diffusion Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2022
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,049
-14.88%
|
-
|
|
Jan 31
2022
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,350
+28.68%
|
-
|
|
Nov 01
2021
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,350
+35.01%
|
-
|
|
May 13
2021
|
Jane H Hollingsworth Director |
BUY
Open market or private purchase
|
Direct |
32,786
+50.0%
|
$0
$0.61 P/Share
|
|
Nov 17
2020
|
William Robert Elder CFO, GC & Secretary |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$0
$0.63 P/Share
|
|
Nov 16
2020
|
William Robert Elder CFO, GC & Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$0
$0.67 P/Share
|
|
Nov 16
2020
|
Robert Joseph Cobuzzi Jr. Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
14,000
+50.0%
|
$0
$0.66 P/Share
|